HIBISTAT ® (0.5% Chlorhexidine Gluconate solution 70% isopropyl alcohol w/w)

Manufacturer
Mölnlycke Health Care US, LLC
Effective date
2011-04-19
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:28:31

Label at a glance#

ProductHibistat
Active ingredientChlorhexidine gluconate, Isopropyl alcohol
Label structure8 sections

Dosage and administration

rub hands vigorously with the towelette for about 15 seconds pay particular attention to nails and interdigital spaces no watering or toweling are necessary

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredientsPurposes
Chlorhexidine gluconate solution 0.5% w/wAntiseptic
Isopropyl alcohol, 70% w/wAntiseptic

Use

INDICATIONS & USAGE SECTION

  • Healthcare Personnel Hand Antiseptic helps reduce bacteria that potentially can cause disease.

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

For external use only

Flammable: keep away from fire or flame.

Do not use

  • if you are allergic to chlorhexidine gluconate or any other ingredients in this preparation
  • as a patient preoperative skin preparation (especially on the head or face)
  • in contact with the meninges
  • in the genital area

When using this product

OTC - WHEN USING SECTION

  • keep out of eyes, ears, and mouth. May cause serious and permanent eye injury if placed or kept in the eye during surgical procedures, or may cause deafness when instilled in the middle ear through perforated eardrums.
  • if contact occurs in any of these areas, rinse with cold water right away

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation, sensitization, or allergic reaction occurs and lasts for 72 hours. These may be signs of a serious condition.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • rub hands vigorously with the towelette for about 15 seconds
  • pay particular attention to nails and interdigital spaces
  • no watering or toweling are necessary

Inactive ingredients

INACTIVE INGREDIENT SECTION

castor oil, glycerin, purified water

Questions?

OTC - QUESTIONS SECTION

1-800-843-8497

PRINCIPAL DISPLAY PANEL - 5mL Wipe Packet

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0234-0587-17

HIBISTAT®
(0.5% Chlorhexidine
Gluconate solution
70% isopropyl alcohol w/w)

Healthcare Personnel Hand Antiseptic

HIBISTAT® provides rapid bactericidal action and has
a persistent antimicrobial effect against a wide range
of microorganisms.

WARNING: For external use only
Flammable:
Keep away from fire or flame.
FOR PROFESSIONAL USE ONLY.

MÖLNLYCKE®
HEALTH CARE

1 Hand Antiseptic Wipe (5mL)

Distributed by Mölnlycke Health Care US, LLC.,
Norcross GA 30092

Principal Display Panel
Principal Display Panel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CHLORHEXIDINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0234-0587-17Hibistat5 mL in 1 PACKETSOLUTION51
0234-0587-17Hibistat50 in 1 CARTONSOLUTION501
0234-0587-27Hibistat15 in 1 CARTONSOLUTION151
0234-0587-27Hibistat5 mL in 1 PACKETSOLUTION51

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0234-0587HIBISTAT (CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL) SOLUTION [MÖLNLYCKE HEALTH CARE US, LLC]1Legacy NDC, 4 package rows20110701_c6f941d6-527e-4fb8-9581-8532dd84e7a8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0234-0587-17EA - Each0234-0587d70e2392-3ff1-4828-8894-0174ef06e0a812012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Chlorhexidine gluconateACTIVE INGREDIENTMOR84MUD8E1
Isopropyl alcoholACTIVE INGREDIENTND2M4163021
ChlorhexidineACTIVE MOIETYR4KO0DY52L1
Isopropyl alcoholACTIVE MOIETYND2M4163021
Castor OilINACTIVE INGREDIENTD5340Y2I9G1
GlycerinINACTIVE INGREDIENTPDC6A3C0OX1
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0234-05870234-0587-17, 0234-0587-27

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 91 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GlycerinGLYCERINPDC6A3C0OXTABLET / PERIODONTAL0.53 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSYSTEM / IONTOPHORESIS168.1 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION/ DROPS / OPHTHALMIC2.5 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUPPOSITORY / VAGINAL227.9 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GTABLET, EXTENDED RELEASE / ORAL23.27 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION / ORAL26208 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXJELLY / VAGINALNAExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GOINTMENT / TOPICAL14.9 %w/wExact identifier — unii candidate
16 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GEMULSION / OPHTHALMIC32 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXGEL / OPHTHALMIC0.88 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXDROPS / NASAL10 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXCONCENTRATE / ORAL1800 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION / INTRAMUSCULAR450 mgExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GINJECTION / INTRAMUSCULAR885 mgExact identifier — unii candidate
16 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GGRANULE, FOR SUSPENSION / ORAL128 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXFILM, EXTENDED RELEASE / BUCCAL34 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXGEL / TRANSDERMAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXTABLET / ORAL42 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GSPRAY / NASALNAExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION / INTRAVENOUS33750 mgExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GGEL / NASAL429 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXCLOTH / TOPICAL0.05 mg/mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXAEROSOL / TOPICAL3 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GTABLET, COATED / ORAL0.9 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXFILM, EXTENDED RELEASE / TRANSDERMAL306.2 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION / SUBCUTANEOUS450 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXJELLY / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GTABLET, FILM COATED / ORAL15.29 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXDROPS / ORAL300 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXEMULSION / INTRAVENOUS2.2 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXCAPSULE, LIQUID FILLED / ORAL185 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSYSTEM / TOPICAL18144 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXPASTE / DENTAL20 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXDOUCHE / VAGINAL1 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSPONGE / TOPICAL2 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXPASTE, DENTIFRICE / DENTAL18 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GCAPSULE / ORAL1.04 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOLUTION / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, SUSPENSION / SUBCUTANEOUS1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXTABLET, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSUSPENSION/ DROPS / ORAL750 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXGEL / TOPICAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXSOAP / TOPICAL0.76 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
Castor OilCASTOR OILD5340Y2I9GTABLET / ORAL17 mgExact identifier — unii candidate
16 equally ranked IID candidates
GlycerinGLYCERINPDC6A3C0OXINJECTION, EMULSION / INTRAVENOUS24100 mgExact identifier — unii candidate
75 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018300-001HIBISTATCHLORHEXIDINE GLUCONATE0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N018300-001HIBISTAT0.5%SOLUTION / TOPICALRLD, RS, Approved before 1982f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
21c3470f-a2a8-43a4-8b14-7c57e3dd2287c6f941d6-527e-4fb8-9581-8532dd84e7a82011-04-19WarningsExact identifier
spl id: 21c3470f-a2a8-43a4-8b14-7c57e3dd2287
spl set id: c6f941d6-527e-4fb8-9581-8532dd84e7a8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.